Spouting Rock Asset Management, LLC Neuronetics, Inc. Transaction History

Spouting Rock Asset Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.07 - $2.92 $459 - $648	-222 Reduced 1.29%	17,049 $36,000
Q1 2023 May 10, 2023	SELL	$2.81 - $6.71 $769 - $1,838	-274 Reduced 1.56%	17,271 $50,000
Q4 2022 Feb 13, 2023	SELL	$2.74 - $6.87 $9,362 - $23,474	-3,417 Reduced 16.3%	17,545 $120,000
Q3 2022 Nov 08, 2022	BUY	$2.35 - $4.66 $24,714 - $49,009	10,517 Added 100.69%	20,962 $67,000
Q2 2022 Aug 10, 2022	BUY	$2.09 - $3.71 $21,830 - $38,750	10,445 New	10,445 $34,000
Q3 2021 Nov 15, 2021	SELL	$6.22 - $15.54 $71,629 - $178,958	-11,516 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$10.15 - $17.25 $11,916 - $20,251	1,174 Added 11.35%	11,516 $184,000
Q1 2021 May 17, 2021	SELL	$10.6 - $21.27 $16,313 - $32,734	-1,539 Reduced 12.95%	10,342 $128,000
Q4 2020 Feb 11, 2021	BUY	$4.95 - $11.45 $58,810 - $136,037	11,881 New	11,881 $131,000
Q3 2020 Nov 16, 2020	SELL	$1.82 - $5.87 $21,024 - $67,810	-11,552 Closed	0 $0
Q2 2020 Aug 03, 2020	SELL	$1.41 - $2.61 $11,721 - $21,696	-8,313 Reduced 41.85%	11,552 $22,000
Q1 2020 Jun 11, 2020	BUY	$1.28 - $4.5 $25,427 - $89,392	19,865 New	19,865 $38,000

13.1M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $19.2M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Spouting Rock Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Spouting Rock Asset Management, LLC with notifications on news.